 in Europe, but is not
currently approved in the United States. It has been shown
to increase pain-free walking distance.93,94
Levocarnitine increases energy substrate for skeletal
muscle metabolism. In clinical trials, a modest improvement

JOURNAL OF VASCULAR SURGERY
Volume 61, Number 3S

Conte and Pomposelli et al 11S

Recommendations: Medical treatment for intermittent claudication